Opinion
Civil Action 7:20-cv-08255-PMH
11-28-2022
Allele Biotechnology and Pharmaceuticals, Inc., Plaintiff, v. Regeneron Pharmaceuticals, Inc., Defendant.
Thomas V. Matthew PERKINS COIE LLP Martin E. Gilmore Thomas V. Matthew Christopher G. Hanewicz (admitted pro hac vice) Andrew T. Dufresne (admitted pro hac vice) Michael R. Laing (admitted pro hac vice) Attorneys for Plaintiff Allele Biotechnology and Pharmaceuticals, Inc
Jury Trial Demanded
Thomas V. Matthew PERKINS COIE LLP Martin E. Gilmore Thomas V. Matthew Christopher G. Hanewicz (admitted pro hac vice) Andrew T. Dufresne (admitted pro hac vice) Michael R. Laing (admitted pro hac vice) Attorneys for Plaintiff Allele Biotechnology and Pharmaceuticals, Inc
MOTION FOR LEAVE TO FILE UNDER SEAL
PHILIP M. HALPERN UNITED STATES DISTRICT JUDGE
PLEASE TAKE NOTICE that the undersigned hereby moves pursuant to the Honorable Philip M. Halpern's Individual Rule 5(B) on behalf of Plaintiff Allele Biotechnology and Pharmaceuticals, Inc. (“Allele”) for an order granting Allele leave to file under seal the Third Amended Complaint. The Third Amended Complaint includes information that Defendant Regeneron Pharmaceuticals, Inc. has designated as confidential. In view of Regeneron's designation, Allele moves to seal the Third Amended Complaint.
DATED: November 22, 2022
Application granted.
Plaintiff is granted leave to file the Third Amended Complaint (Doc. 114) under seal. The Clerk of the Court is respectfully directed to seal Doc. 114 and its attachments, permitting access only by the parties and the Court, but to retain the summary docket for the record.
The Clerk of the Court is respectfully directed to terminate the motion sequence pending at Doc. 113
SO ORDERED.